TNXP
NASDAQ · Biotechnology
Tonix Pharmaceuticals Holdin
$3.01
-0.23 (-7.10%)
Open$3.25
Previous Close$3.24
Day High$3.25
Day Low$2.90
52W High$20.56
52W Low$3.21
Volume—
Avg Volume1.21M
Market Cap62.96M
P/E Ratio—
EPS$-12.92
SectorBiotechnology
Analyst Ratings
Strong Buy
10 analysts
Price Target
+1,253.5% upside
Current
$3.01
$3.01
Target
$40.74
$40.74
$28.14
$40.74 avg
$50.62
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 29.92M | 84.57M | 86.26M |
| Net Income | -283,142,427 | -20,699,385 | -25,319,011 |
| Profit Margin | -946.2% | -24.5% | -29.4% |
| EBITDA | -287,362,952 | -24,990,141 | -25,196,528 |
| Free Cash Flow | — | -20,292,095 | -20,848,476 |
| Rev Growth | — | +3.2% | +20.0% |
| Debt/Equity | — | 0.58 | 0.68 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $295.03 | +0.20% | 50.3 | 520.47B |
| AMGN | Amgen Inc | $465.67 | -0.30% | 26.9 | 252.64B |
| GILD | Gilead Sciences Inc | $168.08 | +0.08% | — | 208.95B |
| VRTX | Vertex Pharmaceuticals Inc | $538.60 | -0.74% | 33.9 | 134.82B |
| REGN | Regeneron Pharmaceuticals | $955.47 | +0.45% | 20.4 | 98.38B |
| ALNY | Alnylam Pharmaceuticals Inc | $165.04 | +5.36% | 7.7 | 20.98B |